CHARACTERISTIC OF CHRONIC MYELOGENOUS LEUKEMIA PATIENTS AT THE POLYCLINIC OF ONCOLOGY, DR. SOETOMO GENERAL ACADEMIC HOSPITAL, SURABAYA, INDONESIA IN 2017
Open Access
- 12 June 2020
- journal article
- Published by Universitas Airlangga in Majalah Biomorfologi
- Vol. 30 (1), 27-33
- https://doi.org/10.20473/mbiom.v30i1.2020.27-33
Abstract
Background: Chronic myelogenous leukemia (CML) is a myeloproliferative neoplasm because of the reciprocal translocation of chromosome 22 to chromosome 9. In the United States, the incidence of CML is 1.9 cases per 100,000 people. Whereas in Indonesia, there is no specific national data on CML prevalence, especially regarding the clinical profile, even though the cancer cases reach 1.4 per 1,000 population. Objective: To evaluate the characteristics and clinical features of CML patients in Dr. Soetomo General Academic Hospital, Surabaya, Indonesia. Materials and Methods: This was a cross-sectional descriptive study with data from the medical records of CML patients in 2017 at Dr. Soetomo General Academic Hospital, Surabaya, Indonesia. The sample in this study was CML patients with positive Breakpoint Clusters Region- Abelson (BCR-ABL), having a minimum age of 18 years and equipped with epidemiological data, complete blood count data, and peripheral blood smear data. Results: Thirty-three patients met the study criteria. The sample was predominantly male, with a ratio of 1.06 : 1 to female patients with a median age of 40 years. Spleno-megaly was found in 87.9% of the patients. The average results of leukocyte, platelet, and hemoglobin counts were 254.58 x 103/μL, 557 x 103/μL, and 9.55 g/dL. From the results of peripheral blood smear obtained normochromic normocytic anisopoikilo-cytosis erythrocyte (57.6%), all patients had a profile of increased leukocytes with blast presence in 97% of the patients, and 51.5% had a profile of an increase in platelets and the discovery of giant platelets in 33.3% of the patients. Conclusion: The sample was predominantly male with the highest incidence at a younger age range of 21-30 years. The clinical characteristics showed high leukocytosis with various stage of maturation and a tendency to develop grade 2 normocytic normochromic anemia and thrombo-cytosis was found in the patients.Keywords
This publication has 9 references indexed in Scilit:
- Prevalence and determinants of non-adherence to Imatinib in the first 3-months treatment among newly diagnosed Ethiopian’s with chronic myeloid leukemiaPLOS ONE, 2019
- Therapeutic Responses of Imatinib and Nilotinib among CML Patients in Hasan Sadikin Hospital BandungIndonesian Journal of Cancer, 2019
- SplenomegalyGastroenterology Clinics of North America, 2018
- Chronic myeloid leukemia: 2018 update on diagnosis, therapy and monitoringAmerican Journal of Hematology, 2018
- OUTCOME OF FRONTLINE TREATMENT WITH “GENERIC” IMATINIB IN ADULT PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN ALGERIAN POPULATION: A MULTICENTER STUDY.Mediterranean Journal of Hematology and Infectious Diseases, 2016
- Epidemiology of chronic myeloid leukaemia: an updateAnnals of Hematology, 2015
- Sex differences in the incidence of chronic myeloid leukemiaRadiation and Environmental Biophysics, 2013
- Gambaran Laboratorium Leukemia Kronik di Bagian Penyakit Dalam RSUP Dr. M. Djamil PadangJurnal Kesehatan Andalas, 2013
- Etiology and Epidemiology of Chronic Myeloid LeukemiaPublished by Springer Science and Business Media LLC ,2012